Ariceum Therapeutics (Ariceum) is a private, clinical stage radiopharmaceutical company currently focused on the diagnosis and precision treatment of certain neuroendocrine and other aggressive, hard-to-treat cancers. The name Ariceum is an anagram of ‘Marie Curie’. Ariceum’s lead targeted systemic radiopharmaceutical product, 177Lu-satoreotide tetraxetan (“satoreotide”) is an antagonist of the somatostatin type 2 (SST2) receptor which is overexpressed in neuroendocrine tumours (NETs), some aggressive cancers such as small cell lung cancer (SCLC), all of which have few treatment options and poor prognosis. Satoreotide is being developed as a ‘theranostic’ pair for the combined diagnosis and targeted radionuclide treatment of these tumours.
Ariceum Therapeutics, launched in 2021, acquiring all rights from Ipsen. Ipsen remains a shareholder in the Company. Ariceum is headquartered in Berlin, with operations in Germany, Switzerland and Australia.
Location: Germany, Berlin
Total raised: $79.19M
Investors 2
Date | Name | Website |
18.04.2023 | Earlybird ... | earlybird.... |
- | Andera Par... | anderapart... |
Funding Rounds 2
Date | Series | Amount | Investors |
18.04.2023 | Series A | $52.37M | Andera Par... |
13.06.2022 | Series A | $26.82M | HealthCap |
Mentions in press and media 11
Date | Title | Description | Source |
12.05.2023 | UCB and Ariceum Therapeutics sign a Strategic Research Colla... | Berlin, Germany, and Brussels, Belgium, 11 May 2023 – Ariceum Therapeutics (Ariceum), a private biot... | healthcap.... |
18.04.2023 | Ariceum Therapeutics Announces Extension of Series A Financi... | Berlin, Germany, 18 April 2023 – Ariceum Therapeutics (Ariceum), a private biotech company developin... | healthcap.... |
18.04.2023 | Andera Partners co-leads a Series A extension round of € 47.... | Andera Partners, a leading European private equity player, today announces the successful completion... | anderapart... |
18.04.2023 | Ariceum Therapeutics Raises €25M; Extends Series A to €47.75... | Ariceum Therapeutics, a Berlin, Germany-based biotech company developing radiopharmaceutical product... | finsmes.co... |
02.02.2023 | Ariceum Therapeutics Appoints Radioligand Expert, Germo Geri... | Berlin, Germany, 1 February 2023 – Ariceum Therapeutics (Ariceum), a private biotech company develop... | healthcap.... |
28.10.2022 | Ariceum Therapeutics and AmbioPharm Enter Strategic Manufact... | BERLIN, Germany and NORTH AUGUSTA, S.C., USA, 27th October 2022 – Ariceum Therapeutics (Ariceum), a ... | healthcap.... |
13.06.2022 | Ariceum Therapeutics Raises EUR 25M in Series A Funding | Ariceum Therapeutics, a Berlin, Germany-based biotech company, raised EUR25M in Series A funding. A... | finsmes.co... |
- | Ariceum Therapeutics | “Ariceum Therapeutics – Novel medicines for systemic targeted radiotherapy (STR) to visualize and tr... | fastfounde... |
- | Ariceum Therapeutics Launches with EUR 25M Series A to Advan... | BERLIN, 8 June 2022 – Ariceum Therapeutics (Ariceum), a private biotech company developing a radioph... | healthcap.... |
- | Ariceum Therapeutics Extends Series A Funding To €47.75 Mill... | Ariceum Therapeutics – a private biotech company developing radiopharmaceutical products for the dia... | pulse2.com... |
Show more